Access detailed search options for content from the Clinical Journal of Oncology Nursing & Oncology Nursing Forum below.
This course provides a comprehensive overview of the treatment of cancer for the advanced practice provider, including important concepts related to antineoplastics, chemotherapy, immunotherapy, surgical oncology, radiation oncology, hematopoietic stem cell transplantation, goals of therapy, clinical trials, and treatment response.
Immune effector cell associated neurotoxicity syndrome (ICANS) is a potentially life-threatening neurotoxicity associated with immune effector cell therapies (e.g., CAR T-cell, tumor-infiltrating lymphocyte (TIL), bispecific T cell engager (BiTE) therapies). Review this huddle card in a group or individually to learn more about immune effector cell associated neurotoxicity syndrome (ICANS).
Review this huddle card in a group or individually to learn more about external beam radiation.
The ONS Biomarker Database was developed as a clinical decision support (CDS) tool to bring the most recent biomarker advances to the point of care.
Biomarker testing through next generation sequencing (NGS) technology has enabled precision oncology to deliver faster, cheaper, and more accurate tumor data.
Paired somatic and germline testing is simultaneous genomic sequencing of a somatic and germline sample from a patient to inform cancer treatment.
Review the growing role of biomarker testing in personalized cancer care with expert Dr. Danielle Fournier, DNP, APRN, AGPCNP-BC, AOCNP. She will present three case studies that highlight biomarker testing work-up, implication for patient care, and patient education.
Nurses may need to collect additional information from the laboratory being used for biomarker testing to help educate patients and families and inform nursing practice.
Apply the biomarker testing nursing process to your practice to guide the delivery of genomic care to all patients with cancer.